A best evidence topic in vascular surgery was written according to a structured protocol. The question addressed was whether, in patients with persistent type 2 endoleak (T2EL) post-endovascular abdominal aortic aneurysm repair (EVAR), intervention is associated with better outcomes than observation. Four hundred and eighty-three papers were found using the reported search, of which 12 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. In a recently published systematic review including 21 744 patients who underwent EVAR, 35.4% of T2ELs resolved spontaneously, 28.5% of secondary interventions were unsuccessful and rupture occurred in only 0.9% of patients with isolated T2EL. Spontaneous sealing in 62-75% of T2ELs were reported by two included studies. A failure rate of 80% associated with transarterial embolization in aggressive treatment of any T2EL was reported by one study. Conversely, another study reported a clinical success rate of 80% associated with the transarterial approach. One study reported that of patients who underwent embolization of a persistent T2EL, 37.9% continued to experience sac growth and 20% had recurrent endoleak at 5 years. One study demonstrated that the transealing procedure for T2EL had a technical success rate of 94.1%. We conclude that the available evidence with regard to management of persistent T2EL is mainly based on retrospective case series. Conflicting results from heterogeneous studies, however, failed to support an optimal threshold for intervention. Considering the reported relatively benign natural course of most T2ELs and the fact that most T2ELs seal spontaneously, conservative management of persistent T2EL in the absence of sac expansion might be appropriate. Where intervention is indicated, imaging should exclude occult type I and III leaks as 25% are not simple T2EL. Translumbar embolization of T2EL is associated with higher success rates than transarterial. Following a successful intervention, continued long-term surveillance is necessary due to the high risk (25-80%) of recurrence. The current evidence indicates that aneurysmal rupture due to an isolated T2EL is rare. Long-term prospective studies may provide better evidence to define the optimal threshold for intervention.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
THREE-PART QUESTION

In [ patients with persistent type 2 endoleak (T2EL) postendovascular abdominal aortic aneurysm repair (EVAR)] is [intervention] associated with better outcomes than [observation]?
CLINICAL SCENARIO
At the vascular multidisciplinary meeting you hear about a 78-year old male with borderline renal insufficiency who was diagnosed with a T2EL after EVAR for a 58-mm abdominal aortic aneurysm. Six-month CT angiography confirmed persistent T2EL and sac enlargement from 58 to 62 mm. It identified the inferior mesenteric artery as the feeding vessel. Considering the patient's comorbidity, it is discussed whether this patient should be treated conservatively or if intervention is warranted. You are unsure which approach is associated with better outcomes and resolve to check the literature yourself to find the best available evidence.
SEARCH STRATEGY
PubMed 1990 to July 2014 with following terms: [(type 2 endoleak OR type II endoleak) AND (embolisation OR embolization OR management) AND (aneurysm)]. The reference lists of selected articles were also searched manually to identify relevant articles. Articles reporting exclusively on the natural course and/or management of T2EL post-EVAR were included and those reporting incidence and/or management of such endoleaks as part of subgroup analyses were excluded. Articles that provided the best evidence to support either conservative management or selective/aggressive management of T2ELs were included. Risk ratio, 4.6, 95% CI 1.9-11.2; P = 0.0001 
Continued
SEARCH OUTCOME
Four hundred and eighty-three papers were found using the reported search. From these, 12 were identified that provided the best evidence to answer the question. These are presented in Table 1 .
RESULTS
Several treatments are available for T2EL post-EVAR. Transarterial and translumbar embolization are the most common approaches [2] . The appropriate management of T2ELs remains controversial. It remains a question whether conservative approach is associated with better outcomes than selective or aggressive treatment of T2ELs [3] .
In their systematic review, Sidloff et al. [2] included 32 retrospective studies reporting on a total of 1515 T2ELs and 393 interventions. Although marked heterogeneity among the studies was detected, translumbar embolization was found to be associated with significantly higher success rates and fewer recurrent endoleaks than transarterial embolization. Furthermore, interventional treatment with either transarterial or translumbar embolization did not result in a stable or decreasing aneurysm sac in a large number of patients. Interestingly, more than one-third of aneurysm ruptures secondary to an isolated T2EL occurred in the absence of sac expansion.
In their meta-analysis of ten series, Karthikesalingam et al. [3] reported outcomes of isolated T2EL in 231 patients and demonstrated that compared with conservative management, there was no significant difference in sac expansion or regression observed with either aggressive or selective intervention. Therefore, they found insufficient evidence to support an optimal threshold for intervention in patients with isolated T2EL. In another review of 10 series in which 124 T2ELs underwent secondary intervention, Gelfand et al. [4] concluded that T2ELs should be managed conservatively for 12 months, expecting that up to 58% will disappear spontaneously. Additionally, they recommended that persistent T2ELs, without sac enlargement, should be monitored closely and if they persist for >12 months, intervention is indicated. However, they argued for early intervention in case of a symptomatic aneurysm, sac enlargement >5 mm or sac pressure >20% of systolic pressure.
Aziz et al. [5] identified 42 patients who underwent intervention for T2EL and found that single or repeated translumbar and transarterial embolization for T2EL with sac growth did not change the rate of sac growth. Moreover, they demonstrated that over two-thirds of patients developed recurrent endoleak after secondary intervention.
Steinmetz et al. [6] found a conservative approach with selective intervention to treat persistent T2EL with aneurysmal enlargement was both safe and cost-effective. They showed that 62% of T2ELs sealed spontaneously within 6 months and of 35 persistent T2ELs, only 5 had an enlarging aneurysm all of which were treated successfully by either translumbar or transarterial embolization with no recurrence or sac growth.
Silverberg et al. [7] further supported the conservative management of T2ELs as they found that T2ELs have a relatively benign course and, in the absence of sac expansion, can be followed up without the need for intervention. In that study, 75% of T2ELs sealed spontaneously ≤5 years when observed without intervention. Furthermore, 80% of patients with T2EL remained free of sac enlargement >5 mm during a 4-year period.
Baum et al. [8] aggressively treated any T2EL and found that, unlike translumbar embolization, a high failure rate (80%) was associated with transarterial embolization. Conversely, Hongo et al. [9] demonstrated that a double coaxial microcatheter technique for transarterial embolization using N-butyl cyanoacrylate and ethiodized oil was associated with technical and clinical success rates of 90 and 80%, respectively, and a complete sac occlusion rate of 65%.
Abularrage et al. [10] evaluated the results of selective intervention for persistent T2EL over a 10-year period. They reported only 43% success rate of secondary intervention and 40% T2EL recurrence rate after secondary intervention. Additionally, they showed that the use of Onyx embolization as the initial secondary intervention was associated with an increased rate of success. Successful Onyx embolization in long-term sac stabilization and prevention of residual endoleaks was also reported by Massis et al. [11] .
Sarac et al. [12] found that continued long-term surveillance is necessary as many patients who underwent embolization of a persistent T2EL continued to experience sac growth (37.9%) or had recurrence (20%) at 5 years. They demonstrated that freedom from a second embolization procedure and from sac growth were much lower at 5 years compared with 1 year.
Recently, Coppi et al. [13] demonstrated that, as a simple less invasive technique with lower cost, the transealing procedure for T2EL has a high technical success rate (94.1%). However, they reported that the freedom from treatment failure rate reduced from 90.0 to 51.4% over 3 years.
CLINICAL BOTTOM LINE
Considering the available evidence from heterogeneous retrospective case series, conservative management of persistent T2EL in the absence of sac expansion might be appropriate as most T2ELs have a benign natural course and seal spontaneously. Where intervention is indicated, occult type I and III endoleaks should be excluded by imaging. Furthermore, long-term surveillance is necessary after successful treatment of T2EL as recurrence is common.
For this patient, who is 6 months post-EVAR and has asymptomatic sac expansion of 4 mm, continued surveillance is recommended.
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